IRIS PubliCatt

Sica, Simona
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.311
EU - Europa 8.132
AS - Asia 2.407
OC - Oceania 121
SA - Sud America 115
AF - Africa 99
Continente sconosciuto - Info sul continente non disponibili 11
Totale 20.196
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.171
DE - Germania 2.193
SE - Svezia 1.629
IT - Italia 1.315
CN - Cina 1.241
IE - Irlanda 580
UA - Ucraina 526
FR - Francia 465
SG - Singapore 441
GB - Regno Unito 424
IN - India 248
RU - Federazione Russa 234
FI - Finlandia 197
ES - Italia 145
AU - Australia 110
CA - Canada 107
TR - Turchia 103
JP - Giappone 84
PL - Polonia 74
IR - Iran 58
NL - Olanda 58
BR - Brasile 56
CI - Costa d'Avorio 55
HK - Hong Kong 52
BE - Belgio 45
CZ - Repubblica Ceca 36
RO - Romania 33
KR - Corea 26
AR - Argentina 25
MX - Messico 25
ID - Indonesia 23
CH - Svizzera 22
PT - Portogallo 21
AT - Austria 19
EG - Egitto 19
GR - Grecia 17
HU - Ungheria 16
IL - Israele 16
NO - Norvegia 15
VN - Vietnam 15
TH - Thailandia 13
PK - Pakistan 12
CL - Cile 11
CO - Colombia 11
NZ - Nuova Zelanda 11
TW - Taiwan 11
DZ - Algeria 10
MY - Malesia 10
SK - Slovacchia (Repubblica Slovacca) 10
BG - Bulgaria 9
SA - Arabia Saudita 9
RS - Serbia 8
LB - Libano 7
PH - Filippine 7
AE - Emirati Arabi Uniti 6
BZ - Belize 6
EU - Europa 6
HR - Croazia 6
A2 - ???statistics.table.value.countryCode.A2??? 5
BA - Bosnia-Erzegovina 5
NP - Nepal 5
PE - Perù 5
ZA - Sudafrica 5
DK - Danimarca 4
EC - Ecuador 4
LT - Lituania 4
MD - Moldavia 4
BY - Bielorussia 3
EE - Estonia 3
IQ - Iraq 3
LI - Liechtenstein 3
MA - Marocco 3
MK - Macedonia 3
BD - Bangladesh 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GE - Georgia 2
GH - Ghana 2
JO - Giordania 2
KE - Kenya 2
KZ - Kazakistan 2
LU - Lussemburgo 2
QA - Qatar 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
UZ - Uzbekistan 2
BO - Bolivia 1
CY - Cipro 1
IS - Islanda 1
LV - Lettonia 1
MC - Monaco 1
MM - Myanmar 1
MT - Malta 1
PS - Palestinian Territory 1
SC - Seychelles 1
Totale 20.196
Salva come PNG Salva come JPEG
Città #
Chandler 1.551
Ashburn 770
Dublin 571
Jacksonville 405
San Mateo 370
Dearborn 304
Wilmington 303
Woodbridge 274
Milan 271
Ann Arbor 267
Nanjing 254
Singapore 244
Houston 206
Beijing 205
Redwood City 198
Boston 191
Princeton 191
Moscow 187
Cattolica 174
Fairfield 161
Seattle 154
New York 136
Lancaster 131
Nürnberg 130
Lawrence 118
Los Angeles 116
Rome 116
Redmond 112
Oviedo 111
Marseille 110
Nanchang 110
Chicago 98
Hangzhou 86
Bremen 84
Munich 69
Izmir 68
Boardman 64
Norwalk 62
Mountain View 57
Abidjan 55
Warsaw 54
Kunming 48
Cambridge 47
Hebei 47
Helsinki 43
Florence 42
Brussels 41
Shenyang 41
Tianjin 38
Zhengzhou 37
Pune 36
Hefei 34
Hong Kong 34
Busto Arsizio 33
London 32
Washington 32
Auburn Hills 31
Changsha 31
Jiaxing 30
Leawood 28
Toronto 28
San Francisco 27
Guangzhou 26
Brno 24
University Park 23
Philadelphia 22
Phoenix 22
Augusta 21
Brisbane 21
Shanghai 21
Adelaide 20
Buffalo 20
Bologna 19
Rochester 19
Tokyo 19
Brooklyn 18
Lappeenranta 18
Melbourne 18
Buenos Aires 17
São Paulo 17
Amsterdam 16
Jinan 16
Naples 16
Atlanta 15
Portland 15
San Diego 15
Frankfurt am Main 14
Hanoi 14
Lanzhou 14
Sydney 14
Falls Church 13
Fremont 13
Padova 13
Tehran 13
Hyderabad 12
Kyoto 12
Ottawa 12
Seoul 12
Berlin 11
Chengdu 11
Totale 10.534
Salva come PNG Salva come JPEG
Nome #
VITAMIN B12 DEFICIENCY: CORRELATION BETWEEN MTHFR POLYMORPHISMS AND CLINICAL AND LABORATORY FINDINGS 1.987
HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN FIRST LINE TREATMENT FOR HIGH-RISK DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) IN THE RITUXIMAB ERA: AN INTENTION TO TREAT-ANALYSIS 349
Reliability of leukostasis grading score to identify patients with high-risk hyperleukocytosis 301
Elevated lactate dehydrogenase has prognostic relevance in treatment-naïve patients affected by chronic lymphocytic leukemia with trisomy 12 281
Dasatinib first-line: Multicentric Italian experience outside clinical trials 263
Dasatinib first-line: Multicentric Italian experience outside clinical trials 261
Twenty years of unrestricted hematopoietic stem cell collection and storage: impact of Joint Accreditation Committee International Society for Cellular Therapy Europe standards implementation on stem cell storage policy and resource utilization 223
Salivary proteomic analysis and acute graft versus host disease after allogeneic hematopoietic stem cell transplantation 162
Management of infection in PNH patients treated with eculizumab or other complement inhibitors: Unmet clinical needs 148
Severe veno-occlusive disease after autologous peripheral blood stem cell transplantation for high-grade non-Hodgkin lymphoma: report of a successfully managed case and a literature review of veno-occlusive disease. 145
Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcome 141
Prospective study of hepatitis B virus reactivation in patients with hematological malignancies 141
Intralesional administration of rituximab for treatment of CD20 positive orbital lymphoma: safety and efficacy evaluation 139
Correlation between paraproteinaemia and viral reactivation after allo-SCT 135
Bendamustine in combination with rituximab for elderly patients with previously untreated B-cell chronic lymphocytic leukemia: A retrospective analysis of real-life practice in Italian hematology departments 134
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation. 132
MTHFR polymorphysms in myelodysplastic syndromes and therapy-related myeloid neoplasms 130
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 129
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the italian network on secondary leukemias. 129
Carbapenemase-producing Klebsiella pneumoniae and hematologic malignancies 129
Serum of healthy donors receiving granulocyte colony-stimulating factor induces T cell unresponsiveness 127
Efficacy of lenalidomide plus dexamethasone for POEMS syndrome relapsed after autologous peripheral stem-cell transplantation 125
Donor erythrocytosis induced by sorafenib treatment after allogeneic hematopoietic SCT in a patient with acute myeloid leukemia 123
The role of HLA--G 14-bp polymorphism in allo-HSCT after short-term course MTX for GvHD prophylaxis 121
Dose-Dependent Effect of Granulocyte Transfusions in Hematological Patients with Febrile Neutropenia 119
Prospective evaluation of Epstein-Barr virus reactivation after stem cell transplantation: association with monoclonal gammopathy. 118
Increased risk of acute myeloid leukaemia due to polymorphisms in detoxification and DNA repair enzymes. 117
Intralesional administration of rituximab for treatment of CD20 positive orbital lymphoma: Safety and efficacy evaluation. 114
Low incidence of secondary neoplasia after autotransplantation for lymphoproliferative disease: the role of pre-transplant therapy 113
Low-dose valganciclovir as preemptive therapy for cytomegalovirus infection occurring in allogeneic stem cell transplant recipients 112
Highly active antiretroviral therapy and allogeneic CD34(+) peripheral blood progenitor cells transplantation in an HIV/HCV coinfected patient with acute myeloid leukemia 111
Chronic lymphocytic leukemia with eyelid involvement responding to alemtuzumab. 111
Carbapenemase-producingKlebsiella pneumoniaeand Hematologic Malignancies 109
Dasatinib as first-line treatment for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia 106
Clinical reversible myelopathy in T-cell lymphoblastic lymphoma treated with nelarabine and radiotherapy: report of a case and review of literature of an increasing complication 105
Role of 18F-FDG PET-CT for evaluating the response to reduced-intensity conditioning allogeneic transplant in heavily pre-treated patients with chronic lymphocytic leukemia: preliminary results in nine patients. 102
revalence, characteristics and management of occult hepatitis B virus infection in patients with chronic lymphocytic leukemia: a single center experience. 102
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 102
AB0 type does not affect platelet engraftment after autologous peripheral blood stem cell transplant in a series of 249 hematologic patients 101
EXTREME THROMBOCYTOSIS IN CHRONIC MYELOID LEUKEMIA IN THE ERA OF TYROSINE KINASE INHIBITORS 101
in Higher-Risk Myelodysplastic Syndromes and Low Blast Count Acute Myeloid Leukemia: Results of the BMT-AZA Prospective Study 101
Oral fludarabine and cyclophosphamide as front-line chemotherapy in patients with chronic lymphocytic leukemia. The impact of biological parameters in the response duration 100
A T cell lymphoblastic lymphoma with mucormycosis as unusual etiology of acute cerebral ischemia 100
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors. A Registry-Based Study of the Italian Blood and Marrow Transplantation Society (Gitmo) 100
The use of low-dose alemtuzumab in pretreated B-cell chronic lymphocytic leukemia. Leukemia. 99
Prospective evaluation of epstein-barr virus reactivation after stem cell transplantation: association with monoclonal gammopathy. 99
Influence of the JAK2 V617F mutation and inherited thrombophilia on the thrombotic risk among patients with essential thrombocythemia 99
Role of (18)F-FDG PET-CT for evaluating the response to reduced-intensity conditioning allogeneic transplant in heavily pre-treated patients with chronic lymphocytic leukemia: preliminary results in nine patients 98
Work related acute leukemia and mucor mycosis in a boat-builder 97
New and old monoclonal antibodies for the treatment of chronic lymphocytic leukemia 97
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation 97
Hyperleukocytosis and leukostasis: management of a medical emergency 97
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the Italian network on secondary leukemias 96
Hyperleukocytosis and leukostasis: management of a medical emergency 96
Role of fecal calprotectin as biomarker of gastrointestinal GVHD after allogeneic stem cell transplantation 95
H1N1 Influenza among Hematological Patients: Monocentric Influenza Cases from 2011 to 2016 94
Neurologic improvement after peripheral blood stem cell transplantation in poems 93
The role of MTHFR and RFC1 polymorphisms on toxicity and outcome of adult patients with hematological malignancies treated with high-dose methotrexate followed by leucovorin rescue 91
Prevalence, characteristics and management of occult hepatitis B virus infection in patients with chronic lymphocytic leukemia: a single center experience 90
Reduced-intensity conditioning allogeneic transplant in heavily pre-treated chronic lymphocytic leukaemia patients: a single centre experience 89
Autologus stem cell transplantation as bridging rherapy followed by CD19 Car-T cells in relapsed refractory large B cell lymphoma 89
Twenty years of unrestricted hematopoietic stem cell collection and storage: impact of Joint Accreditation Committee International Society for Cellular Therapy Europe standards implementation on stem cell storage policy and resource utilization 88
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 88
Non-tunnelled central venous catheters in adult stem cell transplantation recipients: an effective option 86
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 85
Invasive fungal infections in chronic lymphoproliferative disorders: A monocentric retrospective study 84
Clonal evolution in therapy-related neoplasms 84
MTHFR polymorphisms involved in vitamin B12 deficiency associated with atrophic gastritis 83
Efficacy of Ceftazidime-avibactam Salvage Therapy in Patients with Infections Caused by KPC-producing Klebsiella pneumoniae 82
Chlorambucil plus Rituximab as Front-Line Therapy in Elderly/Unfit Patients Affected by B-Cell Chronic Lymphocytic Leukemia: Results of a Single-Centre Experience 81
Long-term follow up of frontline therapy with fludarabine and cyclophosphamide in chronic lymphocytic leukemia: impact of biological parameters on clinical outcome 80
Treatment of primary plasma cell leukemia with high doses of cyclophosphamide, bortezomib, and dexamethasone followed by double autologous HSCT 80
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey 79
High-dose glucocorticoids plus Ofatumumab in fludarabine/alemtuzumab-resistant B-cell chronic lymphocytic leukemia 77
Randomized phase III trial of retinoic acid and arsenic trioxide versus retinoic acid and chemotherapy in patients with acute promyelocytic leukemia: health-related quality-of-life outcomes 77
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 77
Reduced-intensity conditioning allogeneic transplant in heavily pre-treated chronic lymphocytic leukaemia patients: a single centre experience 76
Molecular characterization of adenovirus from clinical samples through analysis of the hexon and fiber genes 75
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 75
Infections by carbapenem-resistant Klebsiella pneumoniae in SCT recipients: a nationwide retrospective survey from Italy 74
Blinatumomab as a successful and safe therapyin Down syndrome patients with relapsed / refractory b-precursor acute lymphoblastic leukemia: Case report and literature review 74
Drug resistance and BCR-ABL kinase domain mutations in philadelphia chromosome-positive acute lymphoblastic leukemia from the imatinib to the second-generation tyrosine kinase inhibitor era: The main changes are in the type of mutations, but not in the frequency of mutation involvement 73
Fecal but not serum calprotectin is a potential marker of GVHD after stem cell transplantation. 73
Molecular characterization of adenovirus from clinical samples through analysis of the hexon and fiber genes 72
UGT1A1 Polymorphism and Mortality Outcome after Allogeneic Stem Cell Transplantation with Busulfan Based Regimen 72
Alternative donor transplants for severe aplastic anemia: current experience 71
Two types of BCR interactions are positively selected during leukemia development in the Eμ-TCL1 transgenic mouse model of CLL 70
SARS-COV-2 vaccination in patients with paroxysmal nocturnal hemoglobinuria an italian multicenter survey 70
Allogeneic Hemopoietic Stem Cell Transplants in Patients with Acute Myeloid Leukemia (AML) Prepared with Busulfan and Fludarabine (BUFLU) or Thiotepa, Busulfan, and Fludarabine (TBF): A Retrospective Study 69
Lymph node blast crisis in chronic myeloid leukemia mimicking T-immunoblastic lymphoma. 68
Peripheral Blood Hemopoietic Stem Cell Mobilization Regimens in POEMS Syndrome: A Retrospective Study at 2 Hematologic Italian Centers 68
Reduction of hospitalization and transfusion support in patients with acute promyelocytic leukemia treated with arsenic trioxide plus all-trans retinoic acid compared to chemotherapy plus all-trans retinoic acid 68
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey 66
Changes in protein serum levels during stem cell transplantation 66
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 66
Autologous stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma. 66
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 65
Imatinib and polypharmacy in very old patients with chronic myeloid leukemia: Effects on response rate, toxicity and outcome 64
Incidence and Outcome of Invasive Fungal Diseases after Allogeneic Stem Cell Transplantation: A Prospective Study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO) 63
Age influences initial dose and compliance to imatinib in chronic myeloid leukemia elderly patients but concomitant comorbidities appear to influence overall and event-free survival 63
Totale 12.613
Salva come PNG Salva come JPEG
Categoria #
all - tutte 89.173
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 89.173
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.191 0 200 174 156 228 266 230 131 147 209 274 176
2020/20212.211 435 239 76 125 184 109 139 62 292 90 386 74
2021/20222.639 249 128 79 139 163 78 66 392 141 179 510 515
2022/20235.141 753 662 414 713 371 621 258 338 570 170 180 91
2023/20243.841 121 829 176 190 211 540 221 153 165 249 467 519
2024/2025532 419 113 0 0 0 0 0 0 0 0 0 0
Totale 20.700